Operating Lease, Right-of-Use Asset of NovaBridge Biosciences from 01 Jan 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NovaBridge Biosciences quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Jun 2025.
  • NovaBridge Biosciences Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $3,209,000.
NovaBridge Biosciences quarterly Operating Lease, Right-of-Use Asset in CNY history and change rate from 01 Jan 2019 to 30 Jun 2025.
  • NovaBridge Biosciences Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2023 was ¥46,400,000, a 26% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)
Operating Lease, Right-of-Use Asset, Quarterly (CNY)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $3,209,000 30 Jun 2025 6-K 06 Oct 2025 2025 Q2
Q4 2024 $3,597,000 -$180,000 -4.8% 31 Dec 2024 6-K 06 Oct 2025 2025 Q2
Q4 2023 $3,777,000 -$5,375,000 -59% 31 Dec 2023 20-F 03 Apr 2025 2024 FY
Q4 2022 $9,152,000 -$8,546,000 -48% 31 Dec 2022 20-F 01 May 2023 2022 FY
Q2 2022 $15,058,000 30 Jun 2022 6-K 10 Nov 2022 2022 Q2
Q4 2021 $17,698,000 +$15,400,000 +670% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $2,298,000 -$63,000 -2.7% 31 Dec 2020 20-F 28 Apr 2021 2020 FY
Q3 2020 $2,218,000 30 Sep 2020 6-K 05 Feb 2021 2020 Q3
Q4 2019 $2,361,000 31 Dec 2019 20-F 29 Apr 2020 2019 FY

NovaBridge Biosciences Quarterly Operating Lease, Right-of-Use Asset (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 ¥46,400,000 -¥16,725,000 -26% 31 Dec 2023 20-F 30 Apr 2024 2023 FY
Q4 2022 ¥63,125,000 -¥49,656,000 -44% 31 Dec 2022 20-F 30 Apr 2024 2023 FY
Q2 2022 ¥100,860,000 30 Jun 2022 6-K 10 Nov 2022 2022 Q2
Q4 2021 ¥112,781,000 +¥97,784,000 +652% 31 Dec 2021 20-F 01 May 2023 2022 FY
Q4 2020 ¥14,997,000 -¥1,438,000 -8.8% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q3 2020 ¥15,061,000 30 Sep 2020 6-K 05 Feb 2021 2020 Q3
Q4 2019 ¥16,435,000 +¥3,335,000 +25% 31 Dec 2019 20-F 28 Apr 2021 2020 FY
Q4 2018 ¥13,100,000 01 Jan 2019 20-F 29 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.